Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide Plus Standard or Low-Dose Dexamethasone in Multiple Myeloma
NCT00098475Phase 3Active, not recruiting
- Sponsor
- National Cancer Institute
- Start
- Nov 2004
- Primary completion
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lenalidomide in multiple myeloma (MM), sponsored by National Cancer Institute. Started Nov 2004; status: active, not recruiting.
02
Drugs
lenalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00098475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00098475.